| 1 | home about us our | | | | | | | 2 | 0.27% |
| 2 | infoaugurexcom twitter facebook linkedin | | | | | | 1 | 0.14% |
| 3 | biomarkers are substances in | | | | | | | 1 | 0.14% |
| 4 | extracellular space where it | | | | | | 1 | 0.14% |
| 5 | space where it perpetuates | | | | | | | 1 | 0.14% |
| 6 | where it perpetuates disease | | | | | | | 1 | 0.14% |
| 7 | it perpetuates disease processes | | | | | | | 1 | 0.14% |
| 8 | perpetuates disease processes read | | | | | | | 1 | 0.14% |
| 9 | disease processes read more | | | | | | | 1 | 0.14% |
| 10 | are substances in the | | | | | | | 1 | 0.14% |
| 11 | cells is released into | | | | | | | 1 | 0.14% |
| 12 | substances in the body | | | | | | | 1 | 0.14% |
| 13 | in the body that | | | | | | | 1 | 0.14% |
| 14 | the body that inform | | | | | | | 1 | 0.14% |
| 15 | body that inform patient | | | | | | | 1 | 0.14% |
| 16 | that inform patient conditions | | | | | | | 1 | 0.14% |
| 17 | and assist with early | | | | | | | 1 | 0.14% |
| 18 | is released into the | | | | | | | 1 | 0.14% |
| 19 | inside of cells is | | | | | | | 1 | 0.14% |
| 20 | of cells is released | | | | | | | 1 | 0.14% |
| 21 | more our science augurex’s | | | | | | | 1 | 0.14% |
| 22 | patient clinical management for | | | | | | | 1 | 0.14% |
| 23 | clinical management for better | | | | | | | 1 | 0.14% |
| 24 | management for better disease | | | | | | | 1 | 0.14% |
| 25 | for better disease outcomes | | | | | | | 1 | 0.14% |
| 26 | identifyoptimizepersonalize read more our | | | | | | | 1 | 0.14% |
| 27 | read more our science | | | | | | | 1 | 0.14% |
| 28 | autoimmune portfolio centers on | | | | | | | 1 | 0.14% |
| 29 | with early diagnosis optimization | | | | | | | 1 | 0.14% |
| 30 | portfolio centers on the | | | | | | | 1 | 0.14% |
| 31 | centers on the novelty | | | | | | | 1 | 0.14% |
| 32 | on the novelty that the | | | | | | | 1 | 0.14% |
| 33 | the novelty that the 1433η | | | | | | | 1 | 0.14% |
| 34 | protein which is normally inside | | | | | | | 1 | 0.14% |
| 35 | is normally inside of | | | | | | | 1 | 0.14% |
| 36 | normally inside of cells | | | | | | | 1 | 0.14% |
| 37 | assist with early diagnosis | | | | | | | 1 | 0.14% |
| 38 | early diagnosis optimization of | | | | | | | 1 | 0.14% |
| 39 | augurex develops biomarkers that | | | | | | | 1 | 0.14% |
| 40 | forming the basis of | | | | | | | 1 | 0.14% |